努力提高我国心脏再同步治疗的应用水平  

To improve cardiac resynchronization therapy in China

作　　者：华伟[1] 陈新[1] 

机构地区：[1]中国医学科学院心血管病研究所北京协和医学院阜外心血管病医院心律失常中心,100037

出　　处：《中华心律失常学杂志》2010年第3期165-166,共2页Chinese Journal of Cardiac Arrhythmias

摘　　要：心脏再同步治疗（CRT）已成为伴QRS波增宽的慢性心力衰竭患者的有效治疗方法。多中心临床研究证实，CRT不仅能改善慢性心力衰竭伴心脏收缩不同步患者的心功能，提高生活质量，而且可以降低死亡率，改善患者预后。2002年ACC／AHA／NASPE第一次将CRT治疗心力衰竭列入起搏适应证（Ⅱa类）。随着循证医学证据的不断积累，CRT治疗心力衰竭的地位不断提升。Cardiac resynchronization therapy （CRT） has proven to be an effective adjunctive therapy to pharmacologic management in reducing the rate of hospitalization in symptomatic patients with advanced heart-failure,an ejection fraction of 0. 35 or less, and an intraventricular conduction delay of 120 ms or more. In this issue of the Journal, seven papers related to the home monitoring, the appropriate treatment of phrenic nerve stimulation, the predictors of response to CRT, and the surgical implantation of left ventricular epicardial electrode were published. Although there were some shortcoming in those papers, new ideas or information were provided. Despite substantial advances in treatment of heart failure, biggap still have exists in the management of heart failure using CRT between developed countries and china. We should strive to make progress in the diag- noses and treatment of heart failure using CRT.

关 键 词：心脏再同步治疗 慢性心力衰竭患者 ACC/AHA/NASPE 多中心临床研究 应用 QRS波增宽 循证医学证据 CRT 

分 类 号：R541.6[医药卫生—心血管疾病]